SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network ($AVT) is gaining momentum amid discussions about its Polkadot integration and a strategic advisor appointment in the UAE. Community members are considering oversold conditions and a low market cap as potential drivers for a rally. Traders are monitoring volume and potential new exchange listings as key catalysts.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic ($LUNC) is trending as the community discusses potential price targets and the future of the LUNC ecosystem. Speculation around the outcome of Do Kwon's legal situation is fueling some of the conversation, with some traders hoping for a positive impact on the token. Community members are closely watching burn numbers and ecosystem upgrades, while also debating the token's potential for significant gains.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a massive surge, driven by its small float and potential short squeeze, reminding some traders of SMX's previous run. Community members are actively discussing its volatile price action, potential for further gains, and whether shorts will be squeezed even more. The stock's reverse split and news catalysts may be contributing to the increased attention.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending due to an 8K filing indicating plans to seek FDA approval for AXPAXLI based on SOL-1 results, a move seen as bold and potentially accelerating the drug's path to market. Community discussion revolves around the implications of this decision, with some speculating positive data from the trial and potential for a Monday morning press release to further boost investor confidence. The focus remains on AXPAXLI's potential in the wet AMD market and the company's strategic positioning within the broader ophthalmology sector.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a recent announcement of a positive profit outlook, reversing previous losses, which has attracted attention from traders looking for low-float plays. The community is actively discussing potential for a significant price surge, drawing comparisons to similar stocks that have experienced substantial gains. Some traders caution against shorting the stock, citing risks associated with low-float volatility, while others point to potential risks.

Boba Network is a blockchain Layer-2 scaling solution and Hybrid Compute platform offering lightning fast transactions and fees up to 100x less than Layer-1. Our Hybrid Compute technology brings the power of Web2 on-chain for the first time, allowing smart contracts to call any external Web2 API to execute complex algorithms such as machine learning classifiers, pull in real-world or enterprise data in a single atomic transaction, or sync with the latest state of a gaming engine. Leveraging off-chain compute and real-world data, developers and creators can offer an enriched experience unlike anything else on the market today.

Boba Network

Boba Network ($BOBA) is trending amid community excitement around potential partnerships and recent bullish technical indicators. Discussions highlight its potential for significant gains, drawing comparisons to past performance and other altcoins. Investors are closely watching for a breakout, anticipating a run towards previous highs.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending amid discussions around political and economic events, including potential impacts from government policies and trade relations, influencing market sentiment. Community members are debating the repercussions of these macro factors and whether they signal future market corrections. News articles about specific companies held within the ETF, such as Apple, Nvidia, and Tesla, are also fueling interest.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MTVA is trending due to speculative interest in early-stage tech and potential for explosive gains given its low market cap and recent after-hours surge in volume. Community members are actively comparing MTVA's performance to other trending tickers and anticipating further upward momentum. Discussions also involve technical analysis, AI-driven scores, and speculation about potential rallies.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is trending as traders discuss its potential for upside, driven by community excitement around staking rewards and a newly launched DEX. Despite some concerns about liquidity and dilution, the community highlights its low market cap and the recently opened Ethereum bridge, while others debate whether it is a "scam" or a sleeping giant.

Tidal Trust II - YieldMax Universe Fund of Option Income ETFs

YieldMax Universe Fund of Option Income ETFs

$YMAX is trending as investors weigh its high yield against concerns about NAV erosion and reverse splits affecting YieldMax funds. The community is actively discussing whether to hold, drip, or exit positions, with some expressing skepticism about the fund's long-term viability despite attractive distributions. Hedge alerts signal short-term put options strategies amid market uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges

NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1...

NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data

NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival...

NuCana plc (NASDAQ:NCNA) Sees Significant Growth in Short Interest

NuCana plc (NASDAQ:NCNA  Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...

Why NuCana (NCNA) Shares Are Trading Lower

NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs).
read more...

Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)

In a report released today, Robyn Karnauskas from Truist Financial maintained a Buy rating on Nucana (NCNA Research Report). The company's shares...

NuCana Announces Plan to Implement ADS Ratio Change

EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares ( ADSs ) to its ordinary shares from...

Short Interest in NuCana plc (NASDAQ:NCNA) Expands By 2,616.3%

William Blair Comments on NuCana plc's FY2024 Earnings (NASDAQ:NCNA)

NuCana plc (NASDAQ:NCNA  Free Report)  Stock analysts at William Blair issued their FY2024 EPS estimates for NuCana in a research note issued to investors on Thursday, March 21st...

NuCana GAAP EPS of -?0.14

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024...

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc - ADR

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

NCNA
NuCana plc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest NCNA News

NCNANuCana plc